These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 10545082

  • 1. Denaturing gradient gel electrophoresis-based analysis of loss of heterozygosity distinguishes nonobvious, deleterious BRCA1 variants from nonpathogenic polymorphisms.
    de La Hoya M, Díaz-Rubio E, Caldés T.
    Clin Chem; 1999 Nov; 45(11):2028-30. PubMed ID: 10545082
    [No Abstract] [Full Text] [Related]

  • 2. Conditions for single-strand conformation polymorphism (SSCP) analysis of BRCA1 gene using an automated electrophoresis unit.
    Campos B, Díez O, Cortés J, Domènech M, Pericay C, Alonso C, Baiget M.
    Clin Chem Lab Med; 2001 May; 39(5):401-4. PubMed ID: 11434389
    [Abstract] [Full Text] [Related]

  • 3. Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening.
    Andersen TI, Eiken HG, Couch F, Kaada G, Skrede M, Johnsen H, Aloysius TA, Tveit KM, Tranebjaerg L, Dørum A, Møller P, Weber BL, Børresen-Dale AL.
    Hum Mutat; 1998 May; 11(2):166-74. PubMed ID: 9482581
    [Abstract] [Full Text] [Related]

  • 4. A fluorescent multiplex-DGGE screening test for mutations in the BRCA1 gene.
    Kuperstein G, Jack E, Narod SA.
    Genet Test; 2006 May; 10(1):1-7. PubMed ID: 16544996
    [Abstract] [Full Text] [Related]

  • 5. Adaptation of conformation-sensitive gel electrophoresis to an ALFexpress DNA sequencer to screen BRCA1 mutations.
    Blesa JR, Hernández-Yago J.
    Biotechniques; 2000 May; 28(5):1019-25. PubMed ID: 10818710
    [Abstract] [Full Text] [Related]

  • 6. Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer.
    Osorio A, de la Hoya M, Rodríguez-López R, Martínez-Ramírez A, Cazorla A, Granizo JJ, Esteller M, Rivas C, Caldés T, Benítez J.
    Int J Cancer; 2002 May 10; 99(2):305-9. PubMed ID: 11979449
    [Abstract] [Full Text] [Related]

  • 7. A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients.
    Sanz DJ, Acedo A, Infante M, Durán M, Pérez-Cabornero L, Esteban-Cardeñosa E, Lastra E, Pagani F, Miner C, Velasco EA.
    Clin Cancer Res; 2010 Mar 15; 16(6):1957-67. PubMed ID: 20215541
    [Abstract] [Full Text] [Related]

  • 8. No mutations in the XRCC2 gene in BRCA1/2-negative high-risk breast cancer families.
    Rodríguez-López R, Osorio A, Sánchez-Pulido L, De La Hoya M, Barroso A, Caldés T, Benítez J.
    Int J Cancer; 2003 Jan 01; 103(1):136-7. PubMed ID: 12455067
    [No Abstract] [Full Text] [Related]

  • 9. Identification of polymorphisms in the p53 gene by denaturing gradient gel blots.
    Nogueira CP.
    Hum Hered; 1997 Jan 01; 47(1):52-7. PubMed ID: 9017981
    [Abstract] [Full Text] [Related]

  • 10. [Electrophoresis in denaturing gradient gel (DGGE)].
    Bull Cancer; 1998 Mar 01; 85(3):281-2. PubMed ID: 9752320
    [No Abstract] [Full Text] [Related]

  • 11. A novel BRCA2 mutation in an Indonesian family found with a new, rapid, and sensitive mutation detection method based on pooled denaturing gradient gel electrophoresis and targeted sequencing.
    Purnomosari D, Paramita DK, Aryandono T, Pals G, van Diest PJ.
    J Clin Pathol; 2005 May 01; 58(5):493-9. PubMed ID: 15858120
    [Abstract] [Full Text] [Related]

  • 12. Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations.
    Wagner T, Stoppa-Lyonnet D, Fleischmann E, Muhr D, Pagès S, Sandberg T, Caux V, Moeslinger R, Langbauer G, Borg A, Oefner P.
    Genomics; 1999 Dec 15; 62(3):369-76. PubMed ID: 10644434
    [Abstract] [Full Text] [Related]

  • 13. Loss of heterozygosity studies in tumors from families with breast-ovarian cancer syndrome.
    Zelada-Hedman M, Torroella M, Mesquita R, Nordenskjöld M, Skoog L, Lindblom A.
    Hum Genet; 1994 Sep 15; 94(3):231-4. PubMed ID: 8076936
    [Abstract] [Full Text] [Related]

  • 14. Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families.
    Santos C, Peixoto A, Rocha P, Pinto P, Bizarro S, Pinheiro M, Pinto C, Henrique R, Teixeira MR.
    J Mol Diagn; 2014 May 15; 16(3):324-34. PubMed ID: 24607278
    [Abstract] [Full Text] [Related]

  • 15. Denaturing gradient gel electrophoresis detection of polymorphism in a PCR fragment of sheep epidermal growth factor gene.
    Lanneluc I, Mulsant P, Harrison B, Drinkwater RD.
    Anim Genet; 1996 Apr 15; 27(2):99-101. PubMed ID: 8856899
    [Abstract] [Full Text] [Related]

  • 16. BRCA1 Gene Mutation Screening for the Hereditary Breast and/or Ovarian Cancer Syndrome in Breast Cancer Cases: a First High Resolution DNA Melting Analysis in Indonesia.
    Mundhofir FE, Wulandari CE, Prajoko YW, Winarni TI.
    Asian Pac J Cancer Prev; 2016 Apr 15; 17(3):1539-46. PubMed ID: 27039803
    [Abstract] [Full Text] [Related]

  • 17. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
    Shiri-Sverdlov R, Oefner P, Green L, Baruch RG, Wagner T, Kruglikova A, Haitchick S, Hofstra RM, Papa MZ, Mulder I, Rizel S, Bar Sade RB, Dagan E, Abdeen Z, Goldman B, Friedman E.
    Hum Mutat; 2000 Dec 15; 16(6):491-501. PubMed ID: 11102978
    [Abstract] [Full Text] [Related]

  • 18. New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing.
    Kluska A, Balabas A, Paziewska A, Kulecka M, Nowakowska D, Mikula M, Ostrowski J.
    BMC Med Genomics; 2015 May 07; 8():19. PubMed ID: 25948282
    [Abstract] [Full Text] [Related]

  • 19. Analysis of DNA sequence variation at population level by polymerase chain reaction and denaturing gradient gel electrophoresis.
    Lessa EP.
    Methods Enzymol; 1993 May 07; 224():419-28. PubMed ID: 8264402
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.